No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Medicus Pharma Ltd. Announces Change of Auditor
Medicus Pharma Ltd: Innovative D-MNA Product Positions Company for Success With Favorable Buy Rating
Medicus Pharma up 9% in Pre-market Trading as FDA Approves Anti-cancer Patch for Horses
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation From the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
Medicus Pharma Ltd. Expands With Strategic Takeover